Karolinska University Hospital - Pulmonology

Stockholm

1 studies enrolling now · 3 studies all time

What they study most

Cystic Fibrosis

Studies at this site

• Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age — Running, not enrolling
• A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF) — Running, not enrolling
• Evaluation of Long-Term Safety and Efficacy of Vanzacaftor/Tezacaftor/Deutivacaftor in Cystic Fibrosis Participants 1 Year of Age and Older — Enrolling by invitation